Disclosures: Islam Mohamed: Nothing to Disclose, Mohamad Ali Ibrahim: Nothing to Disclose, Nikita Rao: Nothing to Disclose, Bhavik Tadigotla: Nothing to Disclose, Ahmed El sabagh: Nothing to Disclose, Mazen ELsheikh: Nothing to Disclose, Prasun Jalal: Nothing to Disclose 1579 POST-TRANSPLANT OUTCOMES IN PATIENTS WITH AND WITHOUT ALCOHOL RELAPSE FOLLOWING LIVER TRANSPLANTATION FOR ALCOHOLIC ASSOCIATED LIVER DISEASE Rachana Punukollu 1 Nilofar Najafian 1 Suaka Kagbo-Kue 2 Laura budvytyte 1 Margaret Liu 1 Xingjie Li 1 Alyssa McGary 1 David Chascsa 3 Channa Jayasekera 3 Michele Barnhill 1 Blanca Lizaola-Mayo 3 Caroline Jadlowiec 3 Rolland Dickson 1 , 1 Mayo Clinic, 2 Intermountain Health, 3 Mayo Clinic Arizona Background: Alcohol- associated liver disease (ALD) is the most common indication for liver transplantation (LT) in the US
was supported by American Lung Association fellowship RT-232840-N, a UAB CFAR Development grant, and Innovative Young Biotechnologist Award BT/11/IYBA/2018/01 (Department of Biotechnology, Government of India)
Villar M, Aylln N, Alberdi P, Moreno A, Moreno M, Tobes R, et al
Protective effect of L-carnitine in cyclophosphamide-induced germ cell apoptosis
